Crexendo (NASDAQ: CXDO) director awarded 10,000 stock options at $6.47

Rhea-AI Filing Summary

Crexendo, Inc. director and major shareholder Steven G. Mihaylo reported receiving a grant of stock options. The award covers 10,000 stock options at an exercise price of $6.47 per share. According to the disclosure, these options vest in 36 equal monthly installments starting on April 4, 2026, meaning the grant becomes exercisable gradually over three years rather than all at once.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider MIHAYLO STEVEN G

Role Director, 10% Owner

Type	Security	Shares	Price	Value
Grant/Award	Stock Options	10,000	$6.47	$65K

Holdings After Transaction: Stock Options — 10,000 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MIHAYLO STEVEN G

(Last) (First) (Middle)

1225 W WASHINGTON ST

STE 213

(Street)

TEMPE AZ 85288

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Crexendo, Inc. [ CXDO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$6.47	03/04/2026		A		10,000		(1)	03/04/2036	Common Stock	10,000	$6.47	10,000	D

Explanation of Responses:

1. The stock options vest over 36 equal monthly installments beginning on 4/4/2026.

	/s/Steven G Mihaylo	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Crexendo (CXDO) disclose for Steven G. Mihaylo?

Crexendo reported that director and major shareholder Steven G. Mihaylo received a grant of 10,000 stock options at an exercise price of $6.47 per share. The options vest monthly over three years, beginning on April 4, 2026, reflecting equity-based compensation.

How many Crexendo (CXDO) stock options were granted in this Form 4 filing?

The filing shows a grant of 10,000 Crexendo stock options to Steven G. Mihaylo. All 10,000 options are reported as held directly after the transaction, providing a clear count of the derivative securities covered by this award at the time of the disclosure.

What is the exercise price of the Crexendo (CXDO) stock options granted?

The stock options granted to Steven G. Mihaylo have an exercise price of $6.47 per share. This price is the amount he would pay per share upon exercising the options, subject to the vesting schedule that governs when each portion becomes exercisable.

How do the new Crexendo (CXDO) stock options vest for Steven G. Mihaylo?

The options vest over 36 equal monthly installments beginning on April 4, 2026. This means one‑thirty‑sixth of the 10,000 options becomes exercisable each month, spreading full vesting across three years rather than a single cliff date.

Is the Crexendo (CXDO) insider transaction a purchase or an award?

The Form 4 characterizes the transaction as a grant or award acquisition of derivative securities, coded as “A.” It represents stock options granted to Steven G. Mihaylo rather than an open‑market purchase or sale of Crexendo’s common shares for cash.